Nicotinic modulation of intrinsic brain networks in schizophrenia

Biochemical Pharmacology

Volumn 86, Issue 8, 2013, Pages 1163-1172

  Smucny, Jason ^a,b,c   Tregellas, Jason ^a,b,c  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Default network; Nicotinic; Salience network; Schizophrenia; Small world network

Indexed keywords

EID: 84885628243     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2013.06.011     Document Type: Review

References (124)

1. Fenton WS, McGlashan TH, Victor BJ, Blyler CR. Symptoms, subtype, and suicidality in patients with schizophrenia spectrum disorders. Am J Psychiatry 1997;154(2):199-204. (Pubitemid 27053725)
2. Green MF.What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry 1996;153(3):321-30. (Pubitemid 26074706)
3. Iversen LL. Introduction to neuropsychopharmacology. New York: Oxford University Press; 2009.
4. Role LW. Diversity in primary structure and function of neuronal nicotinic acetylcholine receptor channels. Curr Opin Neurobiol 1992;2(3):254-62.
5. Wonnacott S, Barik J, Dickinson J, Jones IW. Nicotinic receptors modulate transmitter cross talk in the CNS: nicotinic modulation of transmitters. J Mol Neurosci 2006;30(1-2):137-40. (Pubitemid 46035352)
6. Le Houezec J. Nicotine: abused substance and therapeutic agent. J Psychiatry Neurosci 1998;23(2):95-108. (Pubitemid 28193514)
7. Paterson D, Nordberg A. Neuronal nicotinic receptors in the human brain. Prog Neurobiol 2000;61(1):75-111. (Pubitemid 30100404)
8. Picciotto MR, Higley MJ, Mineur YS. Acetylcholine as a neuromodulator: cholinergic signaling shapes nervous system function and behavior. Neuron 2012;76(1):116-29.
9. Wallace TL, Porter RH. Targeting the nicotinic alpha7 acetylcholine receptor to enhance cognition in disease. Biochem Pharmacol 2011;82(8):891-903.
10. Deutsch SI, Urbano MR, Neumann SA, Burket JA, Katz E. Cholinergic abnormalities in autism: is there a rationale for selective nicotinic agonist interventions. Clin Neuropharmacol 2010;33(3):114-20.
11. Wilens TE, Decker MW. Neuronal nicotinic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: focus on cognition. Biochem Pharmacol 2007;74(8):1212-23. (Pubitemid 47417927)
12. Philip NS, Carpenter LL, Tyrka AR, Price LH. The nicotinic acetylcholine receptor as a target for antidepressant drug development. Sci World J 2012;2012:104105.
13. Jones CK, Byun N, Bubser M. Muscarinic and nicotinic acetylcholine receptor agonists and allosteric modulators for the treatment of schizophrenia. Neuropsychopharmacology 2012;37(1):16-42.
14. Lynch G, Palmer LC, Gall CM. The likelihood of cognitive enhancement. Pharmacol Biochem Behav 2011;99(2):116-29.
15. Dickerson F, Stallings CR, Origoni AE, Vaughan C, Khushalani S, Schroeder J, et al. Cigarette smoking among persons with schizophrenia or bipolar disorder in routine clinical settings, 1999-2011. Psychiatry Serv 2013;64(1): 44-50.
16. Winterer G. Why do patients with schizophrenia smoke? Curr Opin Psychiatry 2010;23(2):112-9.
17. Freedman R, Leonard S, Gault JM, Hopkins J, Cloninger CR, Kaufmann CA, et al. Linkage disequilibrium for schizophrenia at the chromosome 15q13-14 locus of the alpha7-nicotinic acetylcholine receptor subunit gene (CHRNA7). Am J Med Genet 2001;105(1):20-2.
18. Gault J, Hopkins J, Berger R, Drebing C, Logel J, Walton C, et al. Comparison of polymorphisms in the alpha7 nicotinic receptor gene and its partial duplication in schizophrenic and control subjects. Am J Med Genet B Neuropsychiatry Genet 2003;123B(1):39-49. (Pubitemid 37323262)
19. Leonard S, Freedman R. Genetics of chromosome 15q13-q14 in schizophrenia. Biol Psychiatry 2006;60(2):115-22. (Pubitemid 44026594)
20. Sinkus ML, Lee MJ, Gault J, Logel J, Short M, Freedman R, et al. A 2-base pair deletion polymorphism in the partial duplication of the alpha7 nicotinic acetylcholine gene (CHRFAM7A) on chromosome 15q14 is associated with schizophrenia. Brain Res 2009;1291:1-11.
21. Stephens SH, Logel J, Barton A, Franks A, Schultz J, Short M, et al. Association of the 50-upstream regulatory region of the alpha7 nicotinic acetylcholine receptor subunit gene (CHRNA7) with schizophrenia. Schizophr Res 2009; 109(1-3):102-12.
22. Levin ED, Wilson W, Rose JE, McEvoy J. Nicotine-haloperidol interactions and cognitive performance in schizophrenics. Neuropsychopharmacology 1996; 15(5):429-36. (Pubitemid 26389866)
23. Smith RC, Singh A, Infante M, Khandat A, Kloos A. Effects of cigarette smoking and nicotine nasal spray on psychiatric symptoms and cognition in schizophrenia. Neuropsychopharmacology 2002;27(3):479-97. (Pubitemid 35253795)
24. Smith RC, Warner-Cohen J, Matute M, Butler E, Kelly E, Vaidhyanathaswamy S, et al. Effects of nicotine nasal spray on cognitive function in schizophrenia. Neuropsychopharmacology 2006;31(3):637-43. (Pubitemid 43276979)
25. Adler LE, Hoffer LJ, Griffith J, Waldo MC, Freedman R. Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenics. Biol Psychiatry 1992;32(7):607-16.
26. Lester RA. Activation and desensitization of heteromeric neuronal nicotinic receptors: implications for non-synaptic transmission. Bioorg Med Chem Lett 2004;14(8):1897-900. (Pubitemid 38410858)
27. Quick MW, Lester RA. Desensitization of neuronal nicotinic receptors. J Neurobiol 2002;53(4):457-78. (Pubitemid 35375579)
28. Laviolette SR, van der Kooy D. The neurobiology of nicotine addiction: bridging the gap from molecules to behaviour. Nat Rev Neurosci 2004;5(1):55-65. (Pubitemid 38076184)
29. Office of the Surgeon General. How tobacco smoke causes disease: the biology and behavioral basis for smoking-attributable disease, a report of the surgeon general. Atlanta: Centers for Disease Control and Prevention, Office on Smoking and Health; 2010 [cited 2013 February 21].
30. Olincy A, Freedman R. Nicotinic mechanisms in the treatment of psychotic disorders: a focus on the alpha7 nicotinic receptor. Handb Exp Pharmacol 2012;213:211-32.
31. Hong LE, Thaker GK, McMahon RP, Summerfelt A, Rachbeisel J, Fuller RL, et al. Effects of moderate-dose treatment with varenicline on neurobiological and cognitive biomarkers in smokers and nonsmokers with schizophrenia or schizoaffective disorder. Arch Gen Psychiatry 2011;68(12):1195-206.
32. Williams DK, Wang J, Papke RL. Positive allosteric modulators as an approach to nicotinic acetylcholine receptor-targeted therapeutics: advantages and limitations. Biochem Pharmacol 2011;82(8):915-30.
33. Grupe M, Jensen AA, Ahring PK, Christensen JK, Grunnet M. Unraveling the mechanism of action of NS9283, a positive allosteric modulator of (alpha4)(3) (beta2)(2) nicotinic acetylcholine receptors. Br J Pharmacol 2012.
34. Olincy A, Harris JG, Johnson LL, Pender V, Kongs S, Allensworth D, et al. Proofof-concept trial of an alpha7 nicotinic agonist in schizophrenia. Arch Gen Psychiatry 2006;63(6):630-8. (Pubitemid 43848294)
35. Freedman R, Olincy A, Buchanan RW, Harris JG, Gold JM, Johnson L, et al. Initial phase 2 trial of a nicotinic agonist in schizophrenia. Am J Psychiatry 2008;165(8):1040-7.
36. Lieberman JA, Dunbar G, Segreti AC, Girgis RR, Seoane F, Beaver JS, et al. A randomized exploratory trial of an alpha-7 nicotinic receptor agonist (TC-5619) for cognitive enhancement in schizophrenia. Neuropsychopharmacology 2013.
37. Brown GG, Thompson WK. Functional brain imaging in schizophrenia: selected results and methods. Curr Top Behav Neurosci 2010;4:181-214.
38. Gur RE, Gur RC. Functional magnetic resonance imaging in schizophrenia. Dialogues Clin Neurosci 2010;12(3):333-43.
39. Fox MD, Raichle ME. Spontaneous fluctuations in brain activity observed with functional magnetic resonance imaging. Nat Rev Neurosci 2007;8(9): 700-11. (Pubitemid 47283145)
40. Raichle ME, Mintun MA. Brain work and brain imaging. Annu Rev Neurosci 2006;29:449-76. (Pubitemid 44476853)
41. Whitfield-Gabrieli S, Thermenos HW, Milanovic S, Tsuang MT, Faraone SV, McCarley RW, et al. Hyperactivity and hyperconnectivity of the default network in schizophrenia and in first-degree relatives of persons with schizophrenia. PNAS 2009;106(4):1279-84.
42. Greicius MD, Krasnow B, Reiss AL, Menon V. Functional connectivity in the resting brain: a network analysis of the default mode hypothesis. PNAS 2003;100(1):253-8. (Pubitemid 36078061)
43. Buckner RL, Andrews-Hanna JR, Schacter DL. The brain's default network: anatomy, function, and relevance to disease. Ann NY Acad Sci 2008;1124: 1-38. (Pubitemid 351506788)
44. Whitfield-Gabrieli S, Ford JM. Default mode network activity and connectivity in psychopathology. Annu Rev Clin Psychol 2012;8:49-76.
45. Vincent JL, Patel GH, Fox MD, Snyder AZ, Baker JT, Van Essen DC, et al. Intrinsic functional architecture in the anaesthetizedmonkey brain. Nature 2007;447(7140):83-6. (Pubitemid 46685840)
46. Fukunaga M, Horovitz SG, van Gelderen P, de Zwart JA, Jansma JM, Ikonomidou VN, et al. Large-amplitude, spatially correlated fluctuations in BOLD fMRI signals during extended rest and early sleep stages. Magn Reson Imaging 2006;24(8):979-92. (Pubitemid 44425396)
47. Horovitz SG, Fukunaga M, deZwart JA, van Gelderen P, Fulton SC, Balkin TJ, et al. Lowfrequency BOLD fluctuations during resting wakefulness and light sleep: a simultaneous EEG-fMRI study. Hum Brain Mapp 2008;29(6):671-82. (Pubitemid 351794122)
48. Picchioni D, Fukunaga M, Carr WS, Braun AR, Balkin TJ, Duyn JH, et al. fMRI differences between early and late stage -1 sleep. Neurosci Lett 2008;441(1): 81-5.
49. Menon V. Large-scale brain networks and psychopathology: a unifying triple network model. Trends Cogn Sci 2011;15(10):483-506.
50. Gordon EM, Stollstorff M, Vaidya CJ. Using spatial multiple regression to identify intrinsic connectivity networks involved in working memory performance. Hum Brain Mapp 2012;33(7):1536-52.
51. Garrity AG, Pearlson GD, McKiernan K, Lloyd D, Kiehl KA, Calhoun VD. Aberrant default mode functional connectivity in schizophrenia. Am J Psychiatry 2007;164(3):450-7. (Pubitemid 46513159)
52. Meyer-Lindenberg AS, Olsen RK, Kohn PD, Brown T, Egan MF,Weinberger DR, et al. Regionally specific disturbance of dorsolateral prefrontal-hippocampal functional connectivity in schizophrenia. Arch Gen Psychiatry 2005;62(4): 379-86. (Pubitemid 40471687)
53. Pomarol-Clotet E, Salvador R, Sarro S, Gomar J, Vila F, Martinez A, et al. Failure to deactivate in the prefrontal cortex in schizophrenia: dysfunction of the default mode network. Psychol Med 2008;38(8):1185-93. (Pubitemid 351950156)
54. Jeong B, Kubicki M. Reduced task-related suppression during semantic repetition priming in schizophrenia. Psychiatry Res 2010;181(2):114-20.
55. Jafri MJ, Pearlson GD, Stevens M, Calhoun VD. A method for functional network connectivity among spatially independent resting-state components in schizophrenia. Neuroimage 2008;39(4):1666-81.
56. Liu H, Kaneko Y, Ouyang X, Li L, Hao Y, Chen EY, et al. Schizophrenic patients and their unaffected siblings share increased resting-state connectivity in the task-negative network but not its anticorrelated task-positive network. Schizophr Bull 2012;38(2):285-94.
57. Skudlarski P, Jagannathan K, Anderson K, Stevens MC, Calhoun VD, Skudlarska BA, et al. Brain connectivity is not only lower but different in schizophrenia: a combined anatomical and functional approach. Biol Psychiatry 2010;68(1):61-9.
58. Liang M, Zhou Y, Jiang T, Liu Z, Tian L, Liu H, et al. Widespread functional disconnectivity in schizophrenia with resting-state functional magnetic resonance imaging. Neuroreport 2006;17(2):209-13. (Pubitemid 43100329)
59. Bluhm RL, Miller J, Lanius RA, Osuch EA, Boksman K, Neufeld RW, et al. Spontaneous low-frequency fluctuations in the BOLD signal in schizophrenic patients: anomalies in the default network. Schizophr Bull 2007;33(4): 1004-12. (Pubitemid 47216653)
60. Holt DJ, Cassidy BS, Andrews-Hanna JR, Lee SM, Coombs G, Goff DC, et al. An anterior-to-posterior shift in midline cortical activity in schizophrenia during self-reflection. Biol Psychiatry 2011;69(5):415-23.
61. Frazier CJ, Rollins YD, Breese CR, Leonard S, Freedman R, Dunwiddie TV. Acetylcholine activates an alpha-bungarotoxin-sensitive nicotinic current in rat hippocampal interneurons, but not pyramidal cells. J Neurosci 1998;18(4):1187-95. (Pubitemid 28082405)
62. Miwa JM, Freedman R, Lester HA. Neural systems governed by nicotinic acetylcholine receptors: emerging hypotheses. Neuron 2011;70(1):20-33.
63. Breese CR, Adams C, Logel J, Drebing C, Rollins Y, Barnhart M, et al. Comparison of the regional expression of nicotinic acetylcholine receptor alpha7 mRNA and [125I]-alpha-bungarotoxin binding in human postmortem brain. J Comp Neurol 1997;387(3):385-98. (Pubitemid 27430337)
64. Breese CR, Lee MJ, Adams CE, Sullivan B, Logel J, Gillen KM, et al. Abnormal regulation of high affinity nicotinic receptors in subjects with schizophrenia. Neuropsychopharmacology 2000;23(4):351-64.
65. Freedman R, Hall M, Adler LE, Leonard S. Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia. Biol Psychiatry 1995;38(1):22-33.
66. Hahn B, Ross TJ, Yang Y, Kim I, Huestis MA, Stein EA. Nicotine enhances visuospatial attention by deactivating areas of the resting brain default network. J Neurosci 2007;27(13):3477-89. (Pubitemid 46515135)
67. Tanabe J, Nyberg E, Martin LF, Martin J, Cordes D, Kronberg E, et al. Nicotine effects on default mode network during resting state. Psychopharmacology (Berl) 2011;216(2):287-95.
68. Correa N, Adali T, Calhoun VD. Performance of blind source separation algorithms for fMRI analysis using a group ICA method. Magn Reson Imaging 2007;25(5):684-94. (Pubitemid 46817794)
69. Tregellas JR, Tanabe J, Rojas DC, Shatti S, Olincy A, Johnson L, et al. Effects of an alpha 7-nicotinic agonist on default network activity in schizophrenia. Biol Psychiatry 2011;69(1):7-11.
70. Mortimer AM. Symptom rating scales and outcome in schizophrenia. Br J Psychiatry Suppl 2007;50:s7-14.
71. Palaniyappan L, White TP, Liddle PF. The concept of salience network dysfunction in schizophrenia: from neuroimaging observations to therapeutic opportunities. Curr Top Med Chem 2012.
72. Wylie KP, Tregellas JR. The role of the insula in schizophrenia. Schizophr Res 2010;123(2-3):93-104.
73. Menon V, Uddin LQ. Saliency, switching, attention and control: a network model of insula function. Brain Struct Funct 2010;214(5-6):655-67.
74. Palaniyappan L, Liddle PF. Does the salience network play a cardinal role in psychosis? An emerging hypothesis of insular dysfunction. J Psychiatry Neurosci 2012;37(1):17-27.
75. Koutsouleris N, Gaser C, Jager M, Bottlender R, Frodl T, Holzinger S, et al. Structural correlates of psychopathological symptom dimensions in schizophrenia: a voxel-based morphometric study. Neuroimage 2008;39(4): 1600-12. (Pubitemid 351179408)
76. Chambon V, Pacherie E, Barbalat G, Jacquet P, Franck N, Farrer C. Mentalizing under influence: abnormal dependence on prior expectations in patients with schizophrenia. Brain 2011;134(Pt 12):3728-41.
77. Chan RC, Di X, McAlonan GM, Gong QY. Brain anatomical abnormalities in high-risk individuals, first-episode, and chronic schizophrenia: an activation likelihood estimation meta-analysis of illness progression. Schizophr Bull 2011;37(1):177-88.
78. Ellison-Wright I, Glahn DC, Laird AR, Thelen SM, Bullmore E. The anatomy of first-episode and chronic schizophrenia: an anatomical likelihood estimation meta-analysis. Am J Psychiatry 2008;165(8):1015-23.
79. Palaniyappan L, Mallikarjun P, Joseph V, White TP, Liddle PF. Reality distortion is related to the structure of the salience network in schizophrenia. Psychol Med 2011;41(8):1701-8.
80. Repovs G, Barch DM.Working memory related brain network connectivity in individuals with schizophrenia and their siblings. Front Hum Neurosci 2012;6:137.
81. Mitchell RL, Elliott R, Barry M, Cruttenden A, Woodruff PW. Neural response to emotional prosody in schizophrenia and in bipolar affective disorder. Br J Psychiatry 2004;184:223-30. (Pubitemid 38333761)
82. Phillips ML, Williams L, Senior C, Bullmore ET, Brammer MJ, Andrew C, et al. A differential neural response to threatening and non-threatening negative facial expressions in paranoid and non-paranoid schizophrenics. Psychiatry Res 1999;92(1):11-31. (Pubitemid 29512390)
83. Seiferth NY, Pauly K, Kellermann T, Shah NJ, Ott G, Herpertz-Dahlmann B, et al. Neuronal correlates of facial emotion discrimination in early onset schizophrenia. Neuropsychopharmacology 2009;34(2):477-87.
84. Laurens KR, Ngan ET, Bates AT, Kiehl KA, Liddle PF. Rostral anterior cingulate cortex dysfunction during error processing in schizophrenia. Brain 2003;126 (Pt 3):610-22. (Pubitemid 36240862)
85. Polli FE, Barton JJ, Thakkar KN, Greve DN, Goff DC, Rauch SL, et al. Reduced error-related activation in two anterior cingulate circuits is related to impaired performance in schizophrenia. Brain 2008;131(Pt 4):971-86. (Pubitemid 351499413)
86. Tu PC, Hsieh JC, Li CT, Bai YM, Su TP. Cortico-striatal disconnection within the cingulo-opercular network in schizophrenia revealed by intrinsic functional connectivity analysis: a resting fMRI study. Neuroimage 2012;59(1):238-47.
87. Moran LV, Sampath H, Stein EA, Hong LE. Insular and anterior cingulate circuits in smokers with schizophrenia. Schizophr Res 2012;142(1-3):223-9.
88. Gradin VB, Waiter G, O'Connor A, Romaniuk L, Stickle C, Matthews K, et al. Salience network-midbrain dysconnectivity and blunted reward signals in schizophrenia. Psychiatry Res 2012.
89. Tu P, Buckner RL, Zollei L, Dyckman KA, Goff DC, Manoach DS. Reduced functional connectivity in a right-hemisphere network for volitional ocular motor control in schizophrenia. Brain 2010;133(Pt 2):625-37.
90. White TP, Joseph V, Francis ST, Liddle PF. Aberrant salience network (bilateral insula and anterior cingulate cortex) connectivity during information processing in schizophrenia. Schizophr Res 2010;123(2-3):105-15.
91. Selden NR, Gitelman DR, Salamon-Murayama N, Parrish TB, Mesulam MM. Trajectories of cholinergic pathways within the cerebral hemispheres of the human brain. Brain 1998;121(Pt 12):2249-57. (Pubitemid 28552464)
92. Marutle A, Zhang X, Court J, Piggott M, Johnson M, Perry R, et al. Laminar distribution of nicotinic receptor subtypes in cortical regions in schizophrenia. J Chem Neuroanat 2001;22(1-2):115-26. (Pubitemid 32695514)
93. Stein EA, Pankiewicz J, Harsch HH, Cho JK, Fuller SA, Hoffmann RG, et al. Nicotine-induced limbic cortical activation in the human brain: a functional MRI study. Am J Psychiatry 1998;155(8):1009-15. (Pubitemid 28357723)
94. Hong LE, Gu H, Yang Y, Ross TJ, Salmeron BJ, Buchholz B, et al. Association of nicotine addiction and nicotine's actions with separate cingulate cortex functional circuits. Arch Gen Psychiatry 2009;66(4):431-41.
95. Langer N, Pedroni A, Gianotti LR, Hanggi J, Knoch D, Jancke L. Functional brain network efficiency predicts intelligence. Hum Brain Mapp 2012;33(6): 1393-406.
96. van den Heuvel MP, Stam CJ, Kahn RS, Hulshoff Pol HE. Efficiency of functional brain networks and intellectual performance. J Neurosci 2009;29(23): 7619-24.
97. Wen W, Zhu W, He Y, Kochan NA, Reppermund S, Slavin MJ, et al. Discrete neuroanatomical networks are associated with specific cognitive abilities in old age. J Neurosci 2011;31(4):1204-12.
98. Kitzbichler MG, Henson RN, Smith ML, Nathan PJ, Bullmore ET. Cognitive effort drives workspace configuration of human brain functional networks. J Neurosci 2011;31(22):8259-70.
99. Liu Y, Liang M, Zhou Y, He Y, Hao Y, Song M, et al. Disrupted small-world networks in schizophrenia. Brain 2008;131(Pt 4):945-61. (Pubitemid 351499423)
100. Rubinov M, Knock SA, Stam CJ, Micheloyannis S, Harris AW, Williams LM, et al. Small-world properties of nonlinear brain activity in schizophrenia. Hum Brain Mapp 2009;30(2):403-16.
101. Shi F, Yap PT, Gao W, Lin W, Gilmore JH, Shen D. Altered structural connectivity in neonates at genetic risk for schizophrenia: a combined study using morphological and white matter networks. Neuroimage 2012;62(3): 1622-33.
102. Wang Q, Su TP, Zhou Y, Chou KH, Chen IY, Jiang T, et al. Anatomical insights into disrupted small-world networks in schizophrenia. Neuroimage 2012;59(2):1085-93.
103. Yu Q, Sui J, Rachakonda S, He H, Pearlson G, Calhoun VD. Altered small-world brain networks in temporal lobe in patients with schizophrenia performing an auditory oddball task. Front Syst Neurosci 2011;5:7.
104. Mesulam MM, Geula C. Nucleus basalis (Ch4) and cortical cholinergic innervation in the human brain: observations based on the distribution of acetylcholinesterase and choline acetyltransferase. J Comp Neurol 1988;275(2): 216-40.
105. Lee MG, Chrobak JJ, Sik A, Wiley RG, Buzsaki G. Hippocampal theta activity following selective lesion of the septal cholinergic system. Neuroscience 1994;62(4):1033-47. (Pubitemid 24335599)
106. Buhl EH, Tamas G, Fisahn A. Cholinergic activation and tonic excitation induce persistent gamma oscillations in mouse somatosensory cortex in vitro. J Physiol 1998;513(Pt 1):117-26. (Pubitemid 28528570)
107. Fellous JM, Sejnowski TJ. Cholinergic induction of oscillations in the hippocampal slice in the slow (0.5-2 Hz), theta (5-12 Hz), and gamma (35-70 Hz) bands. Hippocampus 2000;10(2):187-97. (Pubitemid 30216356)
108. Siok CJ, Rogers JA, Kocsis B, Hajos M. Activation of alpha7 acetylcholine receptors augments stimulation-induced hippocampal theta oscillation. Eur J Neurosci 2006;23(2):570-4.
109. Penttonen M, Kamondi A, Acsady L, Buzsaki G. Gamma frequency oscillation in the hippocampus of the rat: intracellular analysis in vivo. Eur J Neurosci 1998;10(2):718-28. (Pubitemid 28325494)
110. Ford JM, Mathalon DH. Neural synchrony in schizophrenia. Schizophr Bull 2008;34(5):904-6.
111. Uhlhaas PJ, Singer W. Abnormal neural oscillations and synchrony in schizophrenia. Nat Rev Neurosci 2010;11(2):100-13.
112. Pasquale V, Massobrio P, Bologna LL, Chiappalone M, Martinoia S. Selforganization and neuronal avalanches in networks of dissociated cortical neurons. Neuroscience 2008;153(4):1354-69.
113. Wylie KP, Rojas DC, Tanabe J, Martin LF, Tregellas JR. Nicotine increases brain functional network efficiency. Neuroimage 2012;63(1):73-80.
114. Smith SM, Fox PT, Miller KL, Glahn DC, Fox PM, Mackay CE, et al. Correspondence of the brain's functional architecture during activation and rest. PNAS 2009;106(31):13040-45.
115. Woodward ND, Rogers B, Heckers S. Functional resting-state networks are differentially affected in schizophrenia. Schizophr Res 2011;130(1-3): 86-93.
116. Wolf ND, Sambataro F, Vasic N, Frasch K, Schmid M, Schonfeldt-Lecuona C, et al. Dysconnectivity of multiple resting-state networks in patients with schizophrenia who have persistent auditory verbal hallucinations. J Psychiatry Neurosci 2011;36(6):366-74.
117. Manoliu A, Riedl V, Zherdin A, Muhlau M, Schwerthoffer D, Scherr M, et al. Aberrant dependence of default mode/central executive network interactions on anterior insular salience network activity in schizophrenia. Schizophr Bull 2013. http://dx.doi.org/10.1093/schbul/sbt037.
118. Rotarska-Jagiela A, van de Ven V, Oertel-Knochel V, Uhlhaas PJ, Vogeley K, Linden DE. Resting-state functional network correlates of psychotic symptoms in schizophrenia. Schizophr Res 2010;117(1):21-30.
119. Hong LE,SchroederM,Ross TJ,BuchholzB, SalmeronBJ,Wonodi I, et al.Nicotine enhances but does not normalize visual sustained attention and the associated brain network in schizophrenia. Schizophr Bull 2011;37(2):416-25.
120. Wallace TL, Ballard TM, Pouzet B, Riedel WJ, Wettstein JG. Drug targets for cognitive enhancement in neuropsychiatric disorders. Pharmacol Biochem Behav 2011;99(2):130-45.
121. Kucinski AJ, Stachowiak MK, Wersinger SR, Lippiello PM, Bencherif M. Alpha7 neuronal nicotinic receptors as targets for novel therapies to treat multiple domains of schizophrenia. Curr Pharm Biotechnol 2011;12(3):437-48.
122. Radek RJ, Kohlhaas KL, Rueter LE, Mohler EG. Treating the cognitive deficits of schizophrenia with alpha4beta2 neuronal nicotinic receptor agonists. Curr Pharm Des 2010;16(3):309-22.
123. AhnAllen CG. The role of the alpha7 nicotinic receptor in cognitive processing of persons with schizophrenia. Curr Opin Psychiatry 2012;25(2): 103-8.
124. Carter CS, Barch DM, Bullmore E, Breiling J, Buchanan RW, Butler P, et al. Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia II: developing imaging biomarkers to enhance treatment development for schizophrenia and related disorders. Biol Psychiatry 2011;70(1): 7-12.